Hims & Hers Health (HIMS) Accumulated Expenses (2019 - 2026)
Hims & Hers Health (HIMS) posted Accumulated Expenses of $90.7 million for Q1 2026, up 15.57% sequentially from $78.5 million in Q4 2025, and up 59.36% YoY from $56.9 million in Q1 2025.
Hims & Hers Health (HIMS) Accumulated Expenses (2019 - 2026) Analysis & Trends
Hims & Hers Health has reported Accumulated Expenses for 8 years, with the latest figure at $90.7 million in Q1 2026.
- Quarterly Accumulated Expenses rose 59.36% year-over-year to $90.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $90.7 million (up 59.36% YoY) and the FY2025 annual result came in at $78.5 million, up 48.11% from the prior year.
- Accumulated Expenses grew to $90.7 million in Q1 2026 per HIMS's latest filing, from $78.5 million in the prior quarter.
- Over five years, Accumulated Expenses peaked at $90.7 million in Q1 2026 and troughed at $9.1 million in Q1 2022.
- A 5-year average of $39.1 million and a median of $28.9 million in 2024 frame the typical range for Accumulated Expenses.
- The sharpest annual moves came in 2022 and 2023: Accumulated Expenses advanced 2.08% in 2022, then jumped 132.74% in 2023.
- Over 5 years, Accumulated Expenses stood at $12.4 million in 2022, then surged by 132.74% to $29.0 million in 2023, then jumped by 82.98% to $53.0 million in 2024, then jumped by 48.11% to $78.5 million in 2025, then gained by 15.57% to $90.7 million in 2026.
- According to Business Quant data, Accumulated Expenses over the past three periods registered $90.7 million, $78.5 million, and $80.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Hims & Hers Health | 7.81 Bn | 6.97 Bn | 480.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 210.26 Mn |
| Mar 31, 2026 | 90.74 Mn |
| Dec 31, 2025 | 78.52 Mn |
| Sep 30, 2025 | 80.13 Mn |
| Jun 30, 2025 | 65.67 Mn |
| Mar 31, 2025 | 56.94 Mn |
| Dec 31, 2024 | 53.01 Mn |
| Sep 30, 2024 | 43.22 Mn |
| Jun 30, 2024 | 28.95 Mn |
| Mar 31, 2024 | 26.71 Mn |
| Dec 31, 2023 | 28.97 Mn |
| Sep 30, 2023 | 27.36 Mn |
| Jun 30, 2023 | 19.61 Mn |
| Mar 31, 2023 | 14.12 Mn |
| Dec 31, 2022 | 12.45 Mn |
| Sep 30, 2022 | 17.15 Mn |
| Jun 30, 2022 | 11.81 Mn |
| Mar 31, 2022 | 9.09 Mn |
| Dec 31, 2021 | 12.19 Mn |
| Sep 30, 2021 | 11.21 Mn |